logo
Select company
Select metric
2.55%Capital Expenditures Margin
VS
Market
57
Sector
56
Industry
55
History
-
$ 9.84Close
$ 5.54 - $ 18.57 52-Week Range
Ticker Information

Ticker

KURA

Company Name

KURA ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KURA ONCOLOGY INC - Capital Expenditures Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KURA - CapEx % Historical data
DateCapital ExpenditureCapital Expenditures MarginRevenues
6/30/2025$ 2.12M2.55%$ 83.28M
3/31/2025$ 680K1%$ 67.99M
12/31/2024$ 472K0.88%$ 53.88M
9/30/2024$ 116K0%$ 0
6/30/2024$ 136K0%$ 0
3/31/2024$ 216K0%$ 0
12/31/2023$ 168K0%$ 0
9/30/2023$ 164K0%$ 0
6/30/2023$ 525K0%$ 0
3/31/2023$ 613K0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KURA ONCOLOGY INC's latest trailing twelve months (TTM) CapEx % stands at 0%.
  • Over the past 5 years, KURA ONCOLOGY INC's average CapEx % has been 1.47%.
  • The median CapEx % for KURA ONCOLOGY INC during this period was 1%
  • KURA ONCOLOGY INC reached its highest CapEx % over the past 5 years at 2.55%.
  • The lowest CapEx % recorded by KURA ONCOLOGY INC in the same timeframe 0.88%

KURA ONCOLOGY INC's CapEx % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx % Benchmarks
CompanyCapEx %
SAGE : SAGE THERAPEUTICS INC -NKTR : NEKTAR THERAPEUTICS -YMAB : Y-MABS THERAPEUTICS INC 0.15%TBPH : THERAVANCE BIOPHARMA INC 0.31%ADCT : ADC THERAPEUTICS SA 0.74%LXRX : LEXICON PHARMACEUTICALS INC 1.34%ZVRA : ZEVRA THERAPEUTICS INC 0.5%GYRE : GYRE THERAPEUTICS INC 0.84%GOSS : GOSSAMER BIO INC 0.2%TRDA : ENTRADA THERAPEUTICS INC 3.39%

Definition of Capital Expenditures Margin

[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
CapEx / Revenues
(=) CapEx %
CapEx % for KURA ONCOLOGY INC is calculated as follows: CapEx [ $ 1.9M ] / Revenues [ $ 0 ]
(=) CapEx % [ 0% ]

KURA - Capital Expenditures Margin, Last 5 years

0.88%

Minimum

Dec 31, 2024

2.55%

Maximum

Jun 30, 2025

1.47%

Average

1%

Median

CapEx % Benchmark Analysis

The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
filtered constituents2.85K
min0%
max15.04%
average3.46%
median2.43%
std3.27%